Julie-Anne Dayer

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Julie-Anne Dayer, Sabine Yerly et al. · The Lancet Infectious Diseases · 2015 · 278 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone

Amanda Tiffany, Pauline Vetter, John G. Mattia et al. · Clinical Infectious Diseases · 2016 · 150 citations · Full text

Veterinary Medicine, Community Health, Infectious Diseases +10

Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study

Suetonia C. Palmer, Marinella Ruospo, Germaine Wong et al. · American Journal of Kidney Diseases · 2015 · 83 citations · Full text

Dentistry, Oral Health Sciences, Geriatric Oral Health +16

The 2014–2015 Ebola outbreak in West Africa: Hands On

Pauline Vetter, Julie-Anne Dayer, Manuel Schibler et al. · Antimicrobial Resistance and Infection Control · 2016 · 71 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +16